Bank of New York Mellon »

Black Diamond Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-09-30 $617k 142k 4.35
2024-06-30 $508k 109k 4.66
2023-03-31 $34k 18k 1.89
2022-12-31 $33k 18k 1.80
2022-09-30 $31k 18k 1.70
2022-06-30 $45k 18k 2.46
2022-03-31 $244k 88k 2.78
2021-12-31 $481k 90k 5.37
2021-09-30 $840k 99k 8.45
2021-06-30 $993k 82k 12.18
2021-03-31 $1.5M 62k 24.24
2020-12-31 $2.0M 64k 32.04
2020-09-30 $1.8M 59k 30.23
2020-06-30 $0 47k 0.00
2020-03-31 $760k 30k 24.96